Accéder directement au contenu Accéder directement à la navigation
Nouvelle interface
Article dans une revue

Evidence-based treatment of chronic immune-mediated neuropathies.

Abstract : Immune-mediated neuropathies are treatable disorders that can result in considerable disability in some cases. Chronic immune-mediated neuropathies include chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy and neuropathy associated with monoclonal gammopathy. In recent years, therapeutic strategies for these disorders have become clearer as a result of large, randomized controlled trials. However, the treatments used can have serious adverse effects and at least 30% of patients do not respond to conventional therapies. The aim of this paper is to review available data on evidence-based immunotherapy of chronic immune-mediated neuropathies and to summarize recent findings and results obtained with new innovative therapies, such as new immunosuppressants and monoclonal antibodies.
Liste complète des métadonnées
Contributeur : Franck Sturtz Connectez-vous pour contacter le contributeur
Soumis le : vendredi 30 septembre 2011 - 09:43:13
Dernière modification le : dimanche 26 juin 2022 - 13:22:31




Laurent Magy, Jean-Michel Vallat. Evidence-based treatment of chronic immune-mediated neuropathies.. Expert Opinion on Pharmacotherapy, 2009, 10 (11), pp.1741-54. ⟨10.1517/14656560903036095⟩. ⟨hal-00627974⟩



Consultations de la notice